India is the main cultivator of all the world’s turmeric crops and consumes 80% of the world’s supply. Due to the high content of the main bioactive component in turmeric (curcumin) Indian turmeric is considered to be the best in the world for medicinal purposes. The Indian city of Erode, located in the South Indian State of Tamil Nadu, is the trading hub for turmeric in the Eastern hemisphere. Erode is so well known for its turmeric production that it is referred to as “Yellow City,” and “Turmeric City” (similar to the way that my living room couch is covered in yellow stains from my frequent turmeric sprinkling on most of the dinners I eat).
Your dosage of CBD oil will depend on a lot of important factors, including your weight, age, lifestyle, personal preferences, medical history, gender, and others. It’s impossible to determine your dosage without a doctor, so be sure you consult them before taking any CBD oil. Generally, it’s best to start slowly with a small dosage and then increase it as needed.
THC, being the first phytocannabinoid discovered, has been much more extensively researched than CBD. THC is strongly psychoactive and because of its ability to alter your behaviour and lose control of what you do it is a popular illegal drug. However, having been shown to be effective as a moderate-strength analgesic, THC has desirable medical applications. It is also a mild pain relief medicine, and can effectively treat symptoms of “serious” diseases such as AIDS and cancer. THC have therefore been legalized for medical purposes. Medical marijuana is safe when prescribed by a doctor and can improve the quality of life for many people suffering from serious and/or chronic diseases.
The anti-emetic and anti-nausea effect of marijuana is a centuries-old known fact. Nevertheless, as early as twenty years ago, the effect was attributed to the actions of THC. Continuous research into other cannabinoids has proven that many other phytocannabinoids produce the same desired effect. At present, the FDA recommends two drugs featuring cannabinoids, in which CBD has the highest concentration, in the treatment of nausea induced by chemotherapy – nabilone and dronabinol. Though in its infancy, promising studies exist which suggest that one day CBD may be incorporated into cancer therapies.
On the other hand, marijuana-derived CBD and anything else derived from a cannabis plant was still classified by the DEA as a Schedule I drug (defined as a drug with "no currently accepted medical use and a high potential for abuse") until October 2018. In 2016, the DEA stated that all extracts containing more than one cannabinoid would remain classified as Schedule I. However, the approval of Epidiolex had an influence in changing this, and prescription CBD drugs with a THC content of below 0.1% have now been reclassified as Schedule 5, the lowest rating.
27-year-old Bekkii Spain from Sligo in Ireland told Cosmopolitan UK how taking CBD oil made an invaluable difference to her intense anxiety. She began having regular panic attacks back in 2015 due to an uncontrollable fear of her throat closing up. But with counselling being far in the horizon and prescribed medication failing to work for her, Bekkii's anxiety only worsened, and eventually she was admitted to her local psychiatric hospital.
CBD also blocked reconsolidation of aversive memories in rat [76]. Briefly, fear memories, when reactivated by re-exposure (retrieval), enter into a labile state in which the memory trace may either be reconsolidated or extinguished [97], and this process may be pharmacologically modulated to achieve reconsolidation blockade or extinction. When administered immediately following retrieval, CBD prevented freezing to the conditioned context upon further re-exposure, and no reinstatement or spontaneous recovery was observed over 3 weeks, consistent with reconsolidation blockade rather than extinction [76]. This effect depended on CB1R activation but not 5-HT1AR activation [76].

In a series of placebo-controlled studies involving 15 healthy volunteers, Fusar-Poli et al. investigated the effects of CBD and THC on task-related blood-oxygen-level dependent functional magnetic resonance imaging activation, specifically the go/no-go and fearful faces tasks [109, 110]. The go/no-go task measures response inhibition, and is associated with activation of medial prefrontal, dorsolateral prefrontal, and parietal areas [111]. Response activation is diminished in PTSD and other anxiety disorders, and increased activation predicts response to treatment [112]. CBD produced no changes in predicted areas (relative to placebo) but reduced activation in the left insula, superior temporal gyrus, and transverse temporal gyrus. The fearful faces task activates the amygdala, and other medial temporal areas involved in emotion processing, and heightened amygdala response activation has been reported in anxiety disorders, including GAD and PTSD [113, 114]. CBD attenuated blood-oxygen-level dependent activation in the left amygdala, and the anterior and posterior cingulate cortex in response to intensely fearful faces, and also reduced amplitude in skin conductance fluctuation, which was highly correlated with amygdala activation [109]. Dynamic causal modeling analysis in this data set further showed CBD reduced forward functional connectivity between the amygdala and anterior cingulate cortex [110].
Cannabidiol (CBD) is one of the 100+ cannabinoids found in cannabis and has been the subject of much research due to its many and varied medical applications. But it’s not only its therapeutic attributes that have sparked such widespread interest in CBD in recent years. The compound is also nonpsychoactive (meaning it does not produce the ‘high’ associated with cannabis use), making it a safe and effective option for patients who may be concerned about the mind altering effects of other cannabinoids such as THC.
Anxiolytic effects of CBD in models of generalized anxiety have been linked to specific receptor mechanisms and brain regions. The midbrain dorsal periaqueductal gray (DPAG) is integral to anxiety, orchestrating autonomic and behavioral responses to threat [91], and DPAG stimulation in humans produces feelings of intense distress and dread [92]. Microinjection of CBD into the DPAG produced anxiolytic effects in the EPM, VGC, and ETM that were partially mediated by activation of 5-HT1ARs but not by CB1Rs [65, 68]. The bed nucleus of the stria terminalis (BNST) serves as a principal output structure of the amygdaloid complex to coordinate sustained fear responses, relevant to anxiety [93]. Anxiolytic effects of CBD in the EPM and VCT occurred upon microinjection into the BNST, where they depended on 5-HT1AR activation [79], and also upon microinjection into the central nucleus of the amygdala [78]. In the prelimbic cortex, which drives expression of fear responses via connections with the amygdala [94], CBD had more complex effects: in unstressed rats, CBD was anxiogenic in the EPM, partially via 5-HT1AR receptor activation; however, following acute restraint stress, CBD was anxiolytic [87]. Finally, the anxiolytic effects of systemic CBD partially depended on GABAA receptor activation in the EPM model but not in the VCT model [61, 62].
In a series of placebo-controlled studies involving 15 healthy volunteers, Fusar-Poli et al. investigated the effects of CBD and THC on task-related blood-oxygen-level dependent functional magnetic resonance imaging activation, specifically the go/no-go and fearful faces tasks [109, 110]. The go/no-go task measures response inhibition, and is associated with activation of medial prefrontal, dorsolateral prefrontal, and parietal areas [111]. Response activation is diminished in PTSD and other anxiety disorders, and increased activation predicts response to treatment [112]. CBD produced no changes in predicted areas (relative to placebo) but reduced activation in the left insula, superior temporal gyrus, and transverse temporal gyrus. The fearful faces task activates the amygdala, and other medial temporal areas involved in emotion processing, and heightened amygdala response activation has been reported in anxiety disorders, including GAD and PTSD [113, 114]. CBD attenuated blood-oxygen-level dependent activation in the left amygdala, and the anterior and posterior cingulate cortex in response to intensely fearful faces, and also reduced amplitude in skin conductance fluctuation, which was highly correlated with amygdala activation [109]. Dynamic causal modeling analysis in this data set further showed CBD reduced forward functional connectivity between the amygdala and anterior cingulate cortex [110].
Important note: Though CBD oil on its own is very safe, it may interact with medications, particularly opioids. Speak with your doctor if you’re concerned about interactions or are unsure about using hemp oil for your conditions. I know it’s tough to find a primary care doctor who understands alternative practices, but there are options like this service that pair you with a doctor who fits your lifestyle.
While these drugs can be effective for many patients, some don’t respond favorably. Certain patients don’t see much improvement, or they can’t tolerate the side effects. Moreover, tranquilizers like Valium and Xanax can be highly addictive. Clearly, alternative treatments are warranted. Could cannabidiol (CBD), the most prominent non-intoxicating constituent in cannabis, provide a viable alternative for currently available anxiety medications? Quite possibly!
The CBDistillery is another brand that cares deeply about their customers. And their concern shows in the CBD products they make. I tried the CBDistillery tinctures for anxiety with the same attitude I carry while using products from other brands – expectations set to a minimum. Thankfully, like many other brands I’ve reviewed here, this one did not disappoint as well.

One of the few side effects of CBD oil is tiredness, but for many, it’s what they seek out in the natural herb. Since pharmaceuticals for aiding sleep pose risk for addiction and leave you feeling groggy the next day, it’s best to go the safe route with non-habit forming Cannabidiol. When searching for strains to combat insomnia, try staying with Indica and CBD-heavy strains to knock you out when you need it most.

CBD is one of over 60 compounds found in cannabis that belong to a class of ingredients called cannabinoids. Until recently, THC (tetrahydrocannabinol) was getting most of the attention because it’s the ingredient in cannabis that produces mind-altering effects in users, but CBD is also present in high concentrations — and the medical world is realizing that its list of medical benefits continues to grow.
In the United States, non-FDA approved CBD products are classified as Schedule I drugs under the Controlled Substances Act.[62] This means that production, distribution, and possession of non-FDA approved CBD products is illegal under federal law. In addition, in 2016 the Drug Enforcement Administration added "marijuana extracts" to the list of Schedule I drugs, which it defined as "an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant."[63] Previously, CBD had simply been considered "marijuana", which is a Schedule I drug.[62][64]
×